RCM
CYNA

Riverloft Capital Management’s CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) CYNA Stock Holding History

Riverloft Capital Management’s Portfolio CYNA Stock Details CYNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-75,000
Closed -$1.22M – 75
2015
Q2 		$1.22M Buy
+75,000
New +$1.23M 0.33% 36

Other funds holding CYNA

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Riverloft Capital Management's CYNA Position: Q3 2015 in Review

Riverloft Capital Management sold out of CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) (CYNA) in Q3 2015, closing a stake of 75,000 shares — an estimated $1.22M sold.

Riverloft Capital Management first reported a position in CYNA in Q2 2015 and held it in 1 quarter. The position peaked at $1.22M in Q2 2015. 28 funds tracked by Wall St. Rank hold CYNA as of Q3 2015.

  • Riverloft Capital Management reported no remaining CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) position as of Q3 2015 after selling out during the quarter.
  • Riverloft Capital Management sold 75,000 CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) shares in Q3 2015, an estimated $1.22M.
  • Riverloft Capital Management first reported a position in CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) in Q2 2015 and held it in 1 quarter.
  • Riverloft Capital Management's CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) position peaked at $1.22M in Q2 2015.
  • 28 funds tracked by Wall St. Rank held CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) as of Q3 2015.

Based on Riverloft Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.